FibroGen Stock News

FibroGen (NASDAQ:FGEN)‘s stock had its “buy” rating reissued by equities research analysts at Mizuho in a note issued to investors on Monday, TipRanks reports. They presently have a $72.00 targe

In a report released today, Difei Yang from Mizuho Securities reiterated a Buy rating on FibroGen (FGEN), with a price target of $72.00. The company's

In a report released today, Difei Yang from Mizuho Securities reiterated a Buy rating on FibroGen (FGEN – Research Report),

FibroGen says UK High Court of Justice holds certain patents to be invalid FGEN

FibroGen Inc:

FibroGen, Inc. (FGEN) today announced that the United Kingdom’s High Court of Justice has held certain patents1 relating to methods of using hypoxia-inducible factor prolyl hydroxylase inhibitors (H

SAN FRANCISCO, April 20, 2020 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the United Kingdom’s High Court of Justice has held...

Arden Trust Co acquired a new position in shares of FibroGen Inc (NASDAQ:FGEN) in the 1st quarter, HoldingsChannel reports. The fund acquired 3,317 shares of the biopharmaceutical company’s stock, v

Bailard Inc. lifted its holdings in FibroGen Inc (NASDAQ:FGEN) by 29.6% during the first quarter, Holdings Channel reports. The institutional investor owned 13,143 shares of the biopharmaceutical comp

Norges Bank acquired a new stake in FibroGen Inc (NASDAQ:FGEN) during the fourth quarter, Holdings Channel reports. The fund acquired 749,729 shares of the biopharmaceutical company’s stock, valued

Alliancebernstein L.P. lifted its stake in FibroGen Inc (NASDAQ:FGEN) by 0.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The

Riptide Bioscience, Inc., today announced that Dame Carol M. Black, FRCP, MACP, FMedSci, Foreign Associate Member of the Institute of Medicine USA, renowned clinician/scientist and eminent expert in s

Keros Therapeutics has braved a turbulent market to pull off an IPO, hitting the top end of its price range and selling 20% more shares than originally planned. The upsized IPO gives Keros the firepow